- Published on
Pathology - Renal Calculi
Crystal aggregates that originate in the renal collecting ducts but can deposit anywhere in the urine tract are known as urinary calculi. The study of epidemiology • Frequent, with a 15% lifetime incidence • The risk is larger for men than for women (3:1). Types of stones • 75% calcium oxalate. Ammonium phosphate of magnesium (15%) 5% of stones are uric acid
The pathogenesis • Hypercalciuria is linked to calcium stones. The majority of patients have absorptive hypercalciuria, a condition in which the intestines absorbs excessive amounts of calcium. Others suffer from renal hypercalciuria, a condition where the proximal tubule's ability to absorb calcium is compromised. A small percentage of people experience hypercalciuria as a result of hypercalcaemia, which is typically brought on by primary hyperparathyroidism. Infections with organisms like Proteus, which produce the urease enzyme that breaks down urea into ammonia, are a major cause of triple stones.
Ammonia causes the urine to become alkaline and encourages the precipitation of magnesium ammonium phosphate salts. Triple stones have the potential to grow to enormous sizes and develop into branching masses that fill the renal pelvis and calyces (staghorn calculus).
• Patients with hyperuricaemia, such as those with gout, and diseases characterized by fast cell turnover, such as leukemias, may develop uric acid stones. The majority of individuals, however, do not have elevated uric acid excretion in their urine or hyperuricaemia. These people are believed to have a propensity to produce slightly acidic urine, which increases the risk of developing uric acid. Presentation: Big stones usually stay inside the kidney. They could be detected during a checkup for recurrent UTls or haematuria, or they could be asymptomatic.
• Urinary colic can result from smaller stones getting lodged in the ureter. The vesicoureteric junction, pelvic brim, and pelviureteric junction are frequently the sites of impaction. Issues · A superadded infection in a blocked urinary tract or any obstruction inside the tract of a single kidney is a urological emergency requiring rapid intervention. > Complete obstruction of the urinary tract necessitates prompt intervention to remove the stone.
Crystal aggregates that originate in the renal collecting ducts but can deposit anywhere in the urine tract are known as urinary calculi. The study of epidemiology • Frequent, with a 15% lifetime incidence • The risk is larger for men than for women (3:1). Types of stones • 75% calcium oxalate. Ammonium phosphate of magnesium (15%) 5% of stones are uric acid
The pathogenesis • Hypercalciuria is linked to calcium stones. The majority of patients have absorptive hypercalciuria, a condition in which the intestines absorbs excessive amounts of calcium. Others suffer from renal hypercalciuria, a condition where the proximal tubule's ability to absorb calcium is compromised. A small percentage of people experience hypercalciuria as a result of hypercalcaemia, which is typically brought on by primary hyperparathyroidism. Infections with organisms like Proteus, which produce the urease enzyme that breaks down urea into ammonia, are a major cause of triple stones.
Ammonia causes the urine to become alkaline and encourages the precipitation of magnesium ammonium phosphate salts. Triple stones have the potential to grow to enormous sizes and develop into branching masses that fill the renal pelvis and calyces (staghorn calculus).
• Patients with hyperuricaemia, such as those with gout, and diseases characterized by fast cell turnover, such as leukemias, may develop uric acid stones. The majority of individuals, however, do not have elevated uric acid excretion in their urine or hyperuricaemia. These people are believed to have a propensity to produce slightly acidic urine, which increases the risk of developing uric acid. Presentation: Big stones usually stay inside the kidney. They could be detected during a checkup for recurrent UTls or haematuria, or they could be asymptomatic.
• Urinary colic can result from smaller stones getting lodged in the ureter. The vesicoureteric junction, pelvic brim, and pelviureteric junction are frequently the sites of impaction. Issues · A superadded infection in a blocked urinary tract or any obstruction inside the tract of a single kidney is a urological emergency requiring rapid intervention. > Complete obstruction of the urinary tract necessitates prompt intervention to remove the stone.
- Published on
Pathology - Obstructive nephropathy
Definition: Renal impairment resulting from blockage in the urinary tract. Epidemiology: Primarily observed in youngsters (attributable to congenital urinary tract defects) and elderly males (resulting from prostatic hyperplasia). Aetiology • Obstruction can manifest at any location within the urinary system Common etiologies encompass urinary calculi, pelviureteric junction obstruction, prostatic hyperplasia, urothelial tumors, and ureteral compression by abdominal or pelvic masses.
Pathogenesis • Renal injury is mostly considered a pressure-related condition, although concurrent infection may also play a role.
Presentation • The clinical manifestations are varied. contingent upon the severity of the condition and its laterality. • Patients may be asymptomatic or exhibit hypertension, polyuria, or renal failure.
Macroscopy • The kidney is diminutive and atrophied, exhibiting hydronephrosis, widespread calyceal dilatation, papillary blunting, and cortical thinning.
Histopathology • The renal parenchyma exhibits characteristics of chronic pyelonephritis, including significant tubulointerstitial fibrosis and tubular atrophy. • Atrophic tubules are frequently dilated and contain proteinaceous material, a phenomenon referred to as 'thyroidization.' • The collecting system has significant chronic inflammation characterized by lymphoid clusters and follicles. • Remaining glomeruli may display hypertrophy and subsequent glomerulosclerosis.
The phrase ‘chronic pyelonephritis’ denotes a set of clinical characteristics that are not exclusive to obstructive nephropathy and may also occur in other conditions, such as reflux nephropathy. Distinction is typically achievable based on the clinical presentation and scarring pattern.
Prognosis: Patients with substantial bilateral illness are at risk of experiencing increasing renal impairment.
Definition: Renal impairment resulting from blockage in the urinary tract. Epidemiology: Primarily observed in youngsters (attributable to congenital urinary tract defects) and elderly males (resulting from prostatic hyperplasia). Aetiology • Obstruction can manifest at any location within the urinary system Common etiologies encompass urinary calculi, pelviureteric junction obstruction, prostatic hyperplasia, urothelial tumors, and ureteral compression by abdominal or pelvic masses.
Pathogenesis • Renal injury is mostly considered a pressure-related condition, although concurrent infection may also play a role.
Presentation • The clinical manifestations are varied. contingent upon the severity of the condition and its laterality. • Patients may be asymptomatic or exhibit hypertension, polyuria, or renal failure.
Macroscopy • The kidney is diminutive and atrophied, exhibiting hydronephrosis, widespread calyceal dilatation, papillary blunting, and cortical thinning.
Histopathology • The renal parenchyma exhibits characteristics of chronic pyelonephritis, including significant tubulointerstitial fibrosis and tubular atrophy. • Atrophic tubules are frequently dilated and contain proteinaceous material, a phenomenon referred to as 'thyroidization.' • The collecting system has significant chronic inflammation characterized by lymphoid clusters and follicles. • Remaining glomeruli may display hypertrophy and subsequent glomerulosclerosis.
The phrase ‘chronic pyelonephritis’ denotes a set of clinical characteristics that are not exclusive to obstructive nephropathy and may also occur in other conditions, such as reflux nephropathy. Distinction is typically achievable based on the clinical presentation and scarring pattern.
Prognosis: Patients with substantial bilateral illness are at risk of experiencing increasing renal impairment.
- Published on
Pathology. - Minimal change disease
Definition: A glomerulopathy with clinical symptoms of nephrotic syndrome and histologically normal glomeruli under light microscopy.
Epidemiology • Uncommon. • Most commonly seen in children aged 2-6 years, but can also affect adults. The exact reason is unknown, however recent data shows it may be due to immunological malfunction. • Research has shown that minimal change disease (MCD) can occur after exposure to drugs, bee stings, or venom.
Pathogenesis: • The podocyte is assumed to be the primary cell involved in MCD. • Normal podocyte activity is compromised, making the glomerular filtration barrier abnormally permeable to proteins.
Presentation: • Nephrotic syndrome. Light microscopy shows typical glomeruli. immune fluorescence • No specific immune deposition is present.
Electron microscopy reveals that podocyte foot processes are highly simplified and lack immune complexes.
Prognosis: • MCD typically results in full recovery, especially in youngsters. Adults with steroid-resistant disease should be closely watched as they may have FSGS (b p. 148) that was not detected during biopsy due to its focused character.
Definition: A glomerulopathy with clinical symptoms of nephrotic syndrome and histologically normal glomeruli under light microscopy.
Epidemiology • Uncommon. • Most commonly seen in children aged 2-6 years, but can also affect adults. The exact reason is unknown, however recent data shows it may be due to immunological malfunction. • Research has shown that minimal change disease (MCD) can occur after exposure to drugs, bee stings, or venom.
Pathogenesis: • The podocyte is assumed to be the primary cell involved in MCD. • Normal podocyte activity is compromised, making the glomerular filtration barrier abnormally permeable to proteins.
Presentation: • Nephrotic syndrome. Light microscopy shows typical glomeruli. immune fluorescence • No specific immune deposition is present.
Electron microscopy reveals that podocyte foot processes are highly simplified and lack immune complexes.
Prognosis: • MCD typically results in full recovery, especially in youngsters. Adults with steroid-resistant disease should be closely watched as they may have FSGS (b p. 148) that was not detected during biopsy due to its focused character.
- Published on
Surgery – Scrubbing up
Scrubbing up helps lessen the chance of infection from the surgeon to the patient. Using bactericidal soaps can lower the amount of organisms that can be cultured from skin swabs, but sterilizing the skin (especially sweat glands and hair follicles) is impossible. Surgical gloves can cause considerable bacterial development within 2 hours due to moisture and heat, even with contemporary cleaning solutions. Bactericidal soaps include chlorhexidine and povidone-iodine.
Protocol
When entering the theatre for the first time, introduce yourself to the senior scrub nurses. It is respectful and safe. It's important to understand the purpose and identity of those in the theatre.
How To Scrub
• Wet your hands and arms first. • Apply disinfecting soap and wash well. • Scrub under nails and excessively filthy areas with a sterile brush and disinfecting soap. Scrubbing too forcefully might cause irritation and have little bactericidal effect. • Use soap to thoroughly clean between fingers, back of hands, beneath fingernails, and base of thumbs. • Rinse well to eliminate soap and prevent skin irritation. • Rinse off, ensuring water runs off elbows. Dry your hands well before moving on to your arms.
How to Gown and Glove
: • Open the gown without touching the exterior 'face'. Do not put your hands through the cuffs. Pick up the right glove with your right hand still in the gown's cuff—palm side down, fingers pointing up towards your forearm. • Fold the other side of the glove's edge 'over' your right hand. • Insert your right hand into the glove. • Grab the left glove by the edge and pull it over the left hand's cuff. • Slide your left hand into the glove and adjust its position. Wearing eye protection and two pairs of gloves is a standard practice to prevent exposure to infectious pathogens. % Infection control strategies include hand hygiene and personal protective equipment (PPE).
Scrubbing up helps lessen the chance of infection from the surgeon to the patient. Using bactericidal soaps can lower the amount of organisms that can be cultured from skin swabs, but sterilizing the skin (especially sweat glands and hair follicles) is impossible. Surgical gloves can cause considerable bacterial development within 2 hours due to moisture and heat, even with contemporary cleaning solutions. Bactericidal soaps include chlorhexidine and povidone-iodine.
Protocol
When entering the theatre for the first time, introduce yourself to the senior scrub nurses. It is respectful and safe. It's important to understand the purpose and identity of those in the theatre.
How To Scrub
• Wet your hands and arms first. • Apply disinfecting soap and wash well. • Scrub under nails and excessively filthy areas with a sterile brush and disinfecting soap. Scrubbing too forcefully might cause irritation and have little bactericidal effect. • Use soap to thoroughly clean between fingers, back of hands, beneath fingernails, and base of thumbs. • Rinse well to eliminate soap and prevent skin irritation. • Rinse off, ensuring water runs off elbows. Dry your hands well before moving on to your arms.
How to Gown and Glove
: • Open the gown without touching the exterior 'face'. Do not put your hands through the cuffs. Pick up the right glove with your right hand still in the gown's cuff—palm side down, fingers pointing up towards your forearm. • Fold the other side of the glove's edge 'over' your right hand. • Insert your right hand into the glove. • Grab the left glove by the edge and pull it over the left hand's cuff. • Slide your left hand into the glove and adjust its position. Wearing eye protection and two pairs of gloves is a standard practice to prevent exposure to infectious pathogens. % Infection control strategies include hand hygiene and personal protective equipment (PPE).
- Published on
Surgery - Surgical Instruments
'Sharps' • Scalps. There are two sizes of handles (4 and 6). Blade types and usage include no. 11 (stab incisions), no. 10 (most skin incisions), no. 15 (fine incisions), and no. 22 (adhesiolysis). • Scissors. It could be dissection or stitch cutting. Dissecting scissors can be straight or curved, such as Mayo, McIndoe, Metzenbaum, and Nelson's.
Forceps • Non-toothed. DeBakey and Adson's forceps are fine, non-toothed instruments used to handle delicate tissues like arteries and bowels. This heavy, non-toothed tool is ideal for general handling, including specimens and sutures. • Toothed. Fine-toothed forceps, such as Gillies' and McIndoe's, are commonly used to handle skin and fascia, as well as to grip delicate tissues precisely. thick-toothed forceps, such as Lane's, are used to grip thick tissues like fascia and scars. • Ring-tipped and microforceps. Used for vascular anastomoses.
Clips and Clamps • Artery clips, such as Spencer-Wells, Robert's (big), and Dunhill's, Mosquito (little), feature serrated jaws. Suitable for vascular clamps, tissue/suture holding. • Tissue clamps, including the Lahey clamp. Clamp with curved tip is commonly used for dissecting vessels. • • Doyen bowel clamp. Non-crushing atraumatic. Babcock/Duval clamp. This non-toothed, semi-atraumatic tissue-holding clamp is commonly employed for holding the bowel. • Use Lane's, Allis, or 'Littlewood' clamps. Tissue clamps with heavy teeth for traumatic use.
Retractors • Self-retaining retractor: • Examples of large retractors include the Goligher retractor for abdominal incisions and the Finichetto retractor for thoracic procedures. • Travers (superficial) and Norfolk and Norwich (deeper) retractors are suitable for minor cutaneous and abdominal incisions. • • • Large handheld retractors, such as Deaver, Kelly, and Morris. Small (e.g. Langenbeck, Kilner/'Catspaw').
'Sharps' • Scalps. There are two sizes of handles (4 and 6). Blade types and usage include no. 11 (stab incisions), no. 10 (most skin incisions), no. 15 (fine incisions), and no. 22 (adhesiolysis). • Scissors. It could be dissection or stitch cutting. Dissecting scissors can be straight or curved, such as Mayo, McIndoe, Metzenbaum, and Nelson's.
Forceps • Non-toothed. DeBakey and Adson's forceps are fine, non-toothed instruments used to handle delicate tissues like arteries and bowels. This heavy, non-toothed tool is ideal for general handling, including specimens and sutures. • Toothed. Fine-toothed forceps, such as Gillies' and McIndoe's, are commonly used to handle skin and fascia, as well as to grip delicate tissues precisely. thick-toothed forceps, such as Lane's, are used to grip thick tissues like fascia and scars. • Ring-tipped and microforceps. Used for vascular anastomoses.
Clips and Clamps • Artery clips, such as Spencer-Wells, Robert's (big), and Dunhill's, Mosquito (little), feature serrated jaws. Suitable for vascular clamps, tissue/suture holding. • Tissue clamps, including the Lahey clamp. Clamp with curved tip is commonly used for dissecting vessels. • • Doyen bowel clamp. Non-crushing atraumatic. Babcock/Duval clamp. This non-toothed, semi-atraumatic tissue-holding clamp is commonly employed for holding the bowel. • Use Lane's, Allis, or 'Littlewood' clamps. Tissue clamps with heavy teeth for traumatic use.
Retractors • Self-retaining retractor: • Examples of large retractors include the Goligher retractor for abdominal incisions and the Finichetto retractor for thoracic procedures. • Travers (superficial) and Norfolk and Norwich (deeper) retractors are suitable for minor cutaneous and abdominal incisions. • • • Large handheld retractors, such as Deaver, Kelly, and Morris. Small (e.g. Langenbeck, Kilner/'Catspaw').
Clamps
Scapel
Forceps
Retractor
- Published on
Surgery - Incisions and Closures
Body cavity incisions Incisions that allow access to each bodily cavity are referred to in general terms.
• Laparotomy. An incision into the peritoneal cavity or retroperitoneal region. Laparotomies are classified based on their location in the abdomen, the tissues they traverse, or the individual who performed them
• Thoracotomy. Accessing the chest cavity, usually in the pleural space or posterior mediastinum. A median sternotomy is a form of thoracotomy that allows access to the anterior and middle mediastinum
. • Craniotomy. Accessing the skull's chambers. Incision closures Incisions are closed using certain basic ideas. • Fascial layers are ideal for supporting apposition and forming the primary abdominal closure. Heavy, non-permanent sutures are commonly used to close wounds. • When performing a craniotomy, bone flaws should be minimized to prevent movement. • Replace defects in fascial or bony structures with transposed or inserted tissues, such as skin, muscle, or polypropylene mesh. • Avoid large cavities and crevices between tissues to prevent infection-causing fluid accumulation.
Body cavity incisions Incisions that allow access to each bodily cavity are referred to in general terms.
• Laparotomy. An incision into the peritoneal cavity or retroperitoneal region. Laparotomies are classified based on their location in the abdomen, the tissues they traverse, or the individual who performed them
• Thoracotomy. Accessing the chest cavity, usually in the pleural space or posterior mediastinum. A median sternotomy is a form of thoracotomy that allows access to the anterior and middle mediastinum
. • Craniotomy. Accessing the skull's chambers. Incision closures Incisions are closed using certain basic ideas. • Fascial layers are ideal for supporting apposition and forming the primary abdominal closure. Heavy, non-permanent sutures are commonly used to close wounds. • When performing a craniotomy, bone flaws should be minimized to prevent movement. • Replace defects in fascial or bony structures with transposed or inserted tissues, such as skin, muscle, or polypropylene mesh. • Avoid large cavities and crevices between tissues to prevent infection-causing fluid accumulation.
- Published on
Pathology - Focal segmental glomerulosclerosis
It is a primary glomerulopathy defined histologically by sclerosis affecting some, but not all, glomeruli (focal) and engaging just a section of the glomerular tuft (segmental). 2 Segmental glomerulosclerosis is simply an indicator of glomerular damage; it can occur in several circumstances and is not exclusive to FSGS. Meticulous elimination of alternative recognized etiologies of segmental glomerulosclerosis is necessary before to diagnosing FSGS, as this designation indicates a condition anticipated to swiftly advance to end-stage renal failure.
Epidemiology: Rare occurrence.
Aetiology • The cause remains unidentified, however the recurrence of the condition in transplanted kidneys implies the presence of a circulating factor. • An uncommon hereditary variant of the disease is also present. Pathogenesis Recent investigations indicate that the podocyte is the principal source of harm. Podocyte damage results in significant proteinuria, subsequently leading to glomerular scarring and quickly progressive renal failure.
Presentation of nephrotic syndrome.
Light microscopy • Affected glomeruli exhibit collapse of a portion of the tuft, replaced by sclerosis. • The sclerotic segment frequently demonstrates adhesion to the adjacent epithelial cells of Bowman’s space. •
Glomerulosclerosis is typically associated with tubulointerstitial fibrosis surrounding the affected glomerulus. Immunofluorescence • Non-specific trapping of IgM and C3 may be observed in regions of sclerosis. Electron microscopy reveals podocyte foot process effacement. • Immune deposits are absent.
Prognosis: Nearly all instances of FSGS are progressive, with the majority of patients attaining end-stage renal failure within a few years post-diagnosis.
It is a primary glomerulopathy defined histologically by sclerosis affecting some, but not all, glomeruli (focal) and engaging just a section of the glomerular tuft (segmental). 2 Segmental glomerulosclerosis is simply an indicator of glomerular damage; it can occur in several circumstances and is not exclusive to FSGS. Meticulous elimination of alternative recognized etiologies of segmental glomerulosclerosis is necessary before to diagnosing FSGS, as this designation indicates a condition anticipated to swiftly advance to end-stage renal failure.
Epidemiology: Rare occurrence.
Aetiology • The cause remains unidentified, however the recurrence of the condition in transplanted kidneys implies the presence of a circulating factor. • An uncommon hereditary variant of the disease is also present. Pathogenesis Recent investigations indicate that the podocyte is the principal source of harm. Podocyte damage results in significant proteinuria, subsequently leading to glomerular scarring and quickly progressive renal failure.
Presentation of nephrotic syndrome.
Light microscopy • Affected glomeruli exhibit collapse of a portion of the tuft, replaced by sclerosis. • The sclerotic segment frequently demonstrates adhesion to the adjacent epithelial cells of Bowman’s space. •
Glomerulosclerosis is typically associated with tubulointerstitial fibrosis surrounding the affected glomerulus. Immunofluorescence • Non-specific trapping of IgM and C3 may be observed in regions of sclerosis. Electron microscopy reveals podocyte foot process effacement. • Immune deposits are absent.
Prognosis: Nearly all instances of FSGS are progressive, with the majority of patients attaining end-stage renal failure within a few years post-diagnosis.
- Published on
Pathology - Membranous nephropathy
Definition: A glomerulopathy characterized by widespread subepithelial immunological deposits within the glomeruli. Epidemiology: Rare occurrence.
Etiology • The majority of cases are idiopathic, with the immune complexes believed to form in situ. The antigen in these instances remains unidentified. Some cases are due to other illnesses, such as malignancies, pharmaceuticals, infections, and systemic lupus erythematosus (SLE). In these instances, the immune complexes likely originate elsewhere and flow to the kidneys, where they are deposited in the glomeruli.
Pathogenesis Immune complexes in the glomerulus compromise the normal filtration barrier, resulting in significant proteinuria. Presentation of nephrotic syndrome.
Light microscopy • All glomeruli exhibit thickened, rigid capillary loops. • Silver staining reveals 'holes' in the glomerular basement membrane, indicative of immune deposits, and 'spikes' that signify the glomerular basement membrane's response to these deposits. • More advanced cases may additionally demonstrate tubulointerstitial fibrosis. Immunofluorescence Granular deposits of IgG and C3 are, by definition, diffusely present along the capillary loops.
• The presence of deposits of IgA, IgM, and C1q necessitates consideration of membranous nephropathy secondary to systemic lupus erythematosus (SLE). Electron microscopy • Subepithelial electron-dense immune deposits are observed, accompanied by a variable response in the surrounding basement membrane. • Podocytes exhibit diffuse effacement of foot processes. Prognosis: Approximately one-third of patients have illness progression.
Definition: A glomerulopathy characterized by widespread subepithelial immunological deposits within the glomeruli. Epidemiology: Rare occurrence.
Etiology • The majority of cases are idiopathic, with the immune complexes believed to form in situ. The antigen in these instances remains unidentified. Some cases are due to other illnesses, such as malignancies, pharmaceuticals, infections, and systemic lupus erythematosus (SLE). In these instances, the immune complexes likely originate elsewhere and flow to the kidneys, where they are deposited in the glomeruli.
Pathogenesis Immune complexes in the glomerulus compromise the normal filtration barrier, resulting in significant proteinuria. Presentation of nephrotic syndrome.
Light microscopy • All glomeruli exhibit thickened, rigid capillary loops. • Silver staining reveals 'holes' in the glomerular basement membrane, indicative of immune deposits, and 'spikes' that signify the glomerular basement membrane's response to these deposits. • More advanced cases may additionally demonstrate tubulointerstitial fibrosis. Immunofluorescence Granular deposits of IgG and C3 are, by definition, diffusely present along the capillary loops.
• The presence of deposits of IgA, IgM, and C1q necessitates consideration of membranous nephropathy secondary to systemic lupus erythematosus (SLE). Electron microscopy • Subepithelial electron-dense immune deposits are observed, accompanied by a variable response in the surrounding basement membrane. • Podocytes exhibit diffuse effacement of foot processes. Prognosis: Approximately one-third of patients have illness progression.
- Published on
Surgery -Fluid Optimization
Identifying Patients in Need of Fluid Optimization
Preoperative fluid resuscitation can benefit any patient, although certain groups are more likely to require it. Consider less obvious situations of fluid depletion. More patients could benefit from fluid optimization than currently receive it. • Sudden vomiting or diarrhea, maybe due to intestinal blockage, biliary colic, or gastroenteritis.
• Patients who have been immobile or debilitated for a period of time, resulting in reduced fluid intake, such as pancreatitis, chest infections, acute-on-chronic vascular insufficiency, or prolonged sepsis with pyrexia.
• Elderly patients with reduced renal reserve, making fluid balance control less effective.
• Drugs that inhibit renal reactions to fluid fluctuations, such as diuretics. Patients with low body weight and smaller total body fluid volume experience larger effects from similar reductions.
• Children are particularly vulnerable to fluid deprivation and may not exhibit visible physical symptoms. Fluids utilized for optimization. Fluid optimization relies on employing the appropriate volumes and rates. In most cases, isotonic crystalloids are the preferred fluid for balancing out imbalances
• The most often utilized fluid is 0.9% isotonic saline ('normal'). When renal function is adequate, isotonic saline minimizes rapid fluid changes during rehydration and excretes excess sodium (Na+) through the kidneys. Add potassium (K+) only if d K+ is present or probable (e.g., prolonged vomiting, pancreatic or small bowel fistula). Glucose (4%), Hartmann's solution, and Ringer's lactate solution are examples of crystalloids. While Ringer's lactate solution has a fluid composition similar to serum, its theoretical benefits are restricted in practice. Hypertonic (1.8%) and hypotonic (0.45%) saline should be used with caution as they might produce fluid changes in and out of cells, potentially causing harm, especially to neurons. Patients with substantial Na+ balance disorders may require non-isotonic fluid adjustment in HDU. How to Give the Fluids Before administering liquids, it is necessary to determine the volume of depletion. Estimates of losses due to vomiting or diarrhea are typically erroneous. Useful calculations include the following:
• Use a recent correct body weight from normal health for admission, as acute weight loss is primarily water-based.
• If a recent haematocrit from normal health is available, admission haematocrit can be used to determine the degree of haemoconcentration caused by fluid loss. The approximate calculation is: fluid depletion (L) = (PCV1 - PCV2)/PCV1) times 0.7 × weight (kg). (PCV1 = normal haematocrit, PCV2 = current haematocrit.)
• Dehydration, renal disease, GI bleeds, and acute proteolysis raise serum urea more than serum Cr. • Signs of ECF depletion (lax skin tone, reduced sweating, dry mucosae) can be misleading and influenced by age and underlying diseases, such as pyrexia and tachypnea. • Signs of intravascular volume depletion, such as hypotension and tachycardia, can be inaccurate and often occur after losing 10-15% of body water. Once the volume of fluid required has been determined, it can be administered. There are several broad guidelines for administering fluid resuscitation. • Young, fit patients with normal renal and cardiac function can receive up to 15% of body fluid volume via fast infusion.
A common treatment involves infusing 1000mL of 0.9% saline over 2 hours, followed by additional 1000mL infusions over 4 hours until corrected. Elderly patients and those with renal or cardiac impairment should have slower infusions to avoid severe intravascular volume overload. A common treatment involves administering 1000mL of 0.9% saline over 4 hours, followed by a 500mL infusion of 0.9% saline over 3-4 hours. Vital signs, including chest auscultation, should be monitored regularly. Complex patients or those who do not react to initial treatment should be discussed with elders and/or other specialists as they may require monitoring in critical care. Monitoring fluid optimization.
Fluid optimization progress can be assessed using the following methods: • Optimized skin turgor and mucosal hydration are unreliable guides due to gradual changes. • Measuring urine output every hour can provide insight into renal blood flow, which in turn affects intravascular fluid volume and cardiac output. It is a reliable indicator of sufficient blood volume replenishment. Although urine flow is adequate, it is not a reliable measure of total body water due to potential intra- and extracellular depletion. A usual minimum is 0.5mL/kg/h. • Monitoring serum urea can offer an approximate guideline if renal function is adequate and there is no acute GI bleeding or proteolysis. In emergency situations, fast fluid infusions may be necessary for patients requiring surgery and fluid optimization before anesthesia. This can be monitored on HDU.
Identifying Patients in Need of Fluid Optimization
Preoperative fluid resuscitation can benefit any patient, although certain groups are more likely to require it. Consider less obvious situations of fluid depletion. More patients could benefit from fluid optimization than currently receive it. • Sudden vomiting or diarrhea, maybe due to intestinal blockage, biliary colic, or gastroenteritis.
• Patients who have been immobile or debilitated for a period of time, resulting in reduced fluid intake, such as pancreatitis, chest infections, acute-on-chronic vascular insufficiency, or prolonged sepsis with pyrexia.
• Elderly patients with reduced renal reserve, making fluid balance control less effective.
• Drugs that inhibit renal reactions to fluid fluctuations, such as diuretics. Patients with low body weight and smaller total body fluid volume experience larger effects from similar reductions.
• Children are particularly vulnerable to fluid deprivation and may not exhibit visible physical symptoms. Fluids utilized for optimization. Fluid optimization relies on employing the appropriate volumes and rates. In most cases, isotonic crystalloids are the preferred fluid for balancing out imbalances
• The most often utilized fluid is 0.9% isotonic saline ('normal'). When renal function is adequate, isotonic saline minimizes rapid fluid changes during rehydration and excretes excess sodium (Na+) through the kidneys. Add potassium (K+) only if d K+ is present or probable (e.g., prolonged vomiting, pancreatic or small bowel fistula). Glucose (4%), Hartmann's solution, and Ringer's lactate solution are examples of crystalloids. While Ringer's lactate solution has a fluid composition similar to serum, its theoretical benefits are restricted in practice. Hypertonic (1.8%) and hypotonic (0.45%) saline should be used with caution as they might produce fluid changes in and out of cells, potentially causing harm, especially to neurons. Patients with substantial Na+ balance disorders may require non-isotonic fluid adjustment in HDU. How to Give the Fluids Before administering liquids, it is necessary to determine the volume of depletion. Estimates of losses due to vomiting or diarrhea are typically erroneous. Useful calculations include the following:
• Use a recent correct body weight from normal health for admission, as acute weight loss is primarily water-based.
• If a recent haematocrit from normal health is available, admission haematocrit can be used to determine the degree of haemoconcentration caused by fluid loss. The approximate calculation is: fluid depletion (L) = (PCV1 - PCV2)/PCV1) times 0.7 × weight (kg). (PCV1 = normal haematocrit, PCV2 = current haematocrit.)
• Dehydration, renal disease, GI bleeds, and acute proteolysis raise serum urea more than serum Cr. • Signs of ECF depletion (lax skin tone, reduced sweating, dry mucosae) can be misleading and influenced by age and underlying diseases, such as pyrexia and tachypnea. • Signs of intravascular volume depletion, such as hypotension and tachycardia, can be inaccurate and often occur after losing 10-15% of body water. Once the volume of fluid required has been determined, it can be administered. There are several broad guidelines for administering fluid resuscitation. • Young, fit patients with normal renal and cardiac function can receive up to 15% of body fluid volume via fast infusion.
A common treatment involves infusing 1000mL of 0.9% saline over 2 hours, followed by additional 1000mL infusions over 4 hours until corrected. Elderly patients and those with renal or cardiac impairment should have slower infusions to avoid severe intravascular volume overload. A common treatment involves administering 1000mL of 0.9% saline over 4 hours, followed by a 500mL infusion of 0.9% saline over 3-4 hours. Vital signs, including chest auscultation, should be monitored regularly. Complex patients or those who do not react to initial treatment should be discussed with elders and/or other specialists as they may require monitoring in critical care. Monitoring fluid optimization.
Fluid optimization progress can be assessed using the following methods: • Optimized skin turgor and mucosal hydration are unreliable guides due to gradual changes. • Measuring urine output every hour can provide insight into renal blood flow, which in turn affects intravascular fluid volume and cardiac output. It is a reliable indicator of sufficient blood volume replenishment. Although urine flow is adequate, it is not a reliable measure of total body water due to potential intra- and extracellular depletion. A usual minimum is 0.5mL/kg/h. • Monitoring serum urea can offer an approximate guideline if renal function is adequate and there is no acute GI bleeding or proteolysis. In emergency situations, fast fluid infusions may be necessary for patients requiring surgery and fluid optimization before anesthesia. This can be monitored on HDU.
- Published on
Surgery – Surgery in Neurological Disease
Surgery for neurological illness.
Cerebrovascular accidents (strokes) Anaesthetic drugs can disrupt cerebrovascular autoregulation, increasing the risk of re-infarction or infarction extension during ischemic episodes. Autoregulation is restored after around 6 weeks. • Haemorrhagic infarctions have a low risk of continued bleeding, especially with thromboprophylaxis. Strategies for reducing risk • Postpone all non-essential surgeries for 6 weeks after infarctions, particularly ischemic ones. • Patients with recent hemorrhagic events may not require thromboprophylaxis. • Control blood pressure throughout perioperative period to prevent hypotension and hypertension and stabilize cerebral blood flow. • Avoid placing the patient's head down on the operating table, as this can increase cerebral venous pressure.
Epilepsy
Paroxysmal neuronal discharge in different parts of the brain can disrupt awareness, movement, and sensory perception. Cerebral space-occupying lesions, uraemia, cerebral oedema, medication toxicity, and hypercalcaemia can all elicit symptoms similar to epilepsy. For patients with known epilepsy, the following measures are recommended. • Determine normal seizure frequency, severity, and prodrome characteristics. • Continue anticonvulsant medication during NBM and immediately after surgery. • If not possible, consult with an anesthetist or neurologist to determine the best bridging regime. • 0 Phenytoin interacts with several medicines used during the perioperative period. • Increase elimination of prednisone, warfarin, and lidocaine. Increase Phenytoin absoption orally through amiodarone, fluconazole, omeprazole, and paroxetine but reduced through antacids with magnesium, calcium, and aluminum and enteral feeding.
Myasthenia gravis
This autoimmune disease causes muscle weakness due to inadequate acetylcholine (ACh) receptors. The disease typically affects young adults and causes symptoms such as ptosis and diplopia, as well as weakness in the neck, limbs, and trunk. Patients may seek thymectomy as a treatment or as an unplanned procedure. Management involves the following: • Continue regular medication. Consider elective post-operative breathing for significant thoracic or upper abdominal surgery, or if the patient has a vital capacity of less than 2L. Consult with an anaesthetist and the ICU. If ventilation is extended after surgery, a tracheostomy may be necessary. Discuss this with the patient during the consent process. • Monitor for respiratory failure after surgery, which could be caused by muscle weakness. Precipitants include hypokalemia, infection, over- or under-treatment, and emotional or physical exertion.
Surgery for neurological illness.
Cerebrovascular accidents (strokes) Anaesthetic drugs can disrupt cerebrovascular autoregulation, increasing the risk of re-infarction or infarction extension during ischemic episodes. Autoregulation is restored after around 6 weeks. • Haemorrhagic infarctions have a low risk of continued bleeding, especially with thromboprophylaxis. Strategies for reducing risk • Postpone all non-essential surgeries for 6 weeks after infarctions, particularly ischemic ones. • Patients with recent hemorrhagic events may not require thromboprophylaxis. • Control blood pressure throughout perioperative period to prevent hypotension and hypertension and stabilize cerebral blood flow. • Avoid placing the patient's head down on the operating table, as this can increase cerebral venous pressure.
Epilepsy
Paroxysmal neuronal discharge in different parts of the brain can disrupt awareness, movement, and sensory perception. Cerebral space-occupying lesions, uraemia, cerebral oedema, medication toxicity, and hypercalcaemia can all elicit symptoms similar to epilepsy. For patients with known epilepsy, the following measures are recommended. • Determine normal seizure frequency, severity, and prodrome characteristics. • Continue anticonvulsant medication during NBM and immediately after surgery. • If not possible, consult with an anesthetist or neurologist to determine the best bridging regime. • 0 Phenytoin interacts with several medicines used during the perioperative period. • Increase elimination of prednisone, warfarin, and lidocaine. Increase Phenytoin absoption orally through amiodarone, fluconazole, omeprazole, and paroxetine but reduced through antacids with magnesium, calcium, and aluminum and enteral feeding.
Myasthenia gravis
This autoimmune disease causes muscle weakness due to inadequate acetylcholine (ACh) receptors. The disease typically affects young adults and causes symptoms such as ptosis and diplopia, as well as weakness in the neck, limbs, and trunk. Patients may seek thymectomy as a treatment or as an unplanned procedure. Management involves the following: • Continue regular medication. Consider elective post-operative breathing for significant thoracic or upper abdominal surgery, or if the patient has a vital capacity of less than 2L. Consult with an anaesthetist and the ICU. If ventilation is extended after surgery, a tracheostomy may be necessary. Discuss this with the patient during the consent process. • Monitor for respiratory failure after surgery, which could be caused by muscle weakness. Precipitants include hypokalemia, infection, over- or under-treatment, and emotional or physical exertion.
